This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1992 Jul;42(7):1422-3.

doi: 10.1212/wnl.42.7.1422.

Clinical and electrophysiologic improvement in Lambert-Eaton syndrome with intravenous immunoglobulin therapy

S J Bird¹

Affiliations

PMID: 1620360
DOI: 10.1212/wnl.42.7.1422

Case Reports

Clinical and electrophysiologic improvement in Lambert-Eaton syndrome with intravenous immunoglobulin therapy

S J Bird. Neurology. 1992 Jul.

. 1992 Jul;42(7):1422-3.

doi: 10.1212/wnl.42.7.1422.

Author

S J Bird¹

Affiliation

¹ Department of Neurology, University of Pennsylvania, Philadelphia 19104.

PMID: 1620360
DOI: 10.1212/wnl.42.7.1422

No abstract available

PubMed Disclaimer

Similar articles

Effect of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome with small-cell lung cancer: correlation with the titer of anti-voltage-gated calcium channel antibody.
Takano H, Tanaka M, Koike R, Nagai H, Arakawa M, Tsuji S. Takano H, et al. Muscle Nerve. 1994 Sep;17(9):1073-5. doi: 10.1002/mus.880170919. Muscle Nerve. 1994. PMID: 8065398 No abstract available.
Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
Bain PG, Motomura M, Newsom-Davis J, Misbah SA, Chapel HM, Lee ML, Vincent A, Lang B. Bain PG, et al. Neurology. 1996 Sep;47(3):678-83. doi: 10.1212/wnl.47.3.678. Neurology. 1996. PMID: 8797464 Clinical Trial.
Use of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome.
Peterlin BL, Flood W, Kothari MJ. Peterlin BL, et al. J Am Osteopath Assoc. 2002 Dec;102(12):682-4. J Am Osteopath Assoc. 2002. PMID: 12501987
Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
Newsom-Davis J. Newsom-Davis J. Semin Neurol. 2003 Jun;23(2):191-8. doi: 10.1055/s-2003-41135. Semin Neurol. 2003. PMID: 12894384 Review.
IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
Illa I. Illa I. J Neurol. 2005 May;252 Suppl 1:I14-8. doi: 10.1007/s00415-005-1104-5. J Neurol. 2005. PMID: 15959667 Review.

See all similar articles

Cited by

Lambert-Eaton myasthenic syndrome.
Seneviratne U, de Silva R. Seneviratne U, et al. Postgrad Med J. 1999 Sep;75(887):516-20. doi: 10.1136/pgmj.75.887.516. Postgrad Med J. 1999. PMID: 10616683 Free PMC article. Review.
Lambert-Eaton Myasthenic Syndrome.
Kesner VG, Oh SJ, Dimachkie MM, Barohn RJ. Kesner VG, et al. Neurol Clin. 2018 May;36(2):379-394. doi: 10.1016/j.ncl.2018.01.008. Neurol Clin. 2018. PMID: 29655456 Free PMC article. Review.
Treatment for Lambert-Eaton myasthenic syndrome.
Keogh M, Sedehizadeh S, Maddison P. Keogh M, et al. Cochrane Database Syst Rev. 2011 Feb 16;2011(2):CD003279. doi: 10.1002/14651858.CD003279.pub3. Cochrane Database Syst Rev. 2011. PMID: 21328260 Free PMC article.
Intravenous immunoglobulin therapy in neurological diseases during pregnancy.
Ringel I, Zettl UK. Ringel I, et al. J Neurol. 2006 Sep;253 Suppl 5:V70-4. doi: 10.1007/s00415-006-5012-0. J Neurol. 2006. PMID: 16998758 Review.
Autoimmune Channelopathies at Neuromuscular Junction.
Huang K, Luo YB, Yang H. Huang K, et al. Front Neurol. 2019 May 17;10:516. doi: 10.3389/fneur.2019.00516. eCollection 2019. Front Neurol. 2019. PMID: 31156543 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.